Radiobiological model comparison of 3D conformal radiotherapy and IMRT plans for the treatment of prostate cancer.
The main aim of radiotherapy is to deliver a dose of radiation that is high enough to destroy the tumour cells while at the same time minimising the damage to normal healthy tissues. Clinically, this has been achieved by assigning a prescription dose to the tumour volume and a set of dose constraints on critical structures. Once an optimal treatment plan has been achieved the dosimetry is assessed using the physical parameters of dose and volume. There has been an interest in using radiobiological parameters to evaluate and predict the outcome of a treatment plan in terms of both a tumour control probability (TCP) and a normal tissue complication probability (NTCP). In this study, simple radiobiological models that are available in a commercial treatment planning system were used to compare three dimensional conformal radiotherapy treatments (3D-CRT) and intensity modulated radiotherapy (IMRT) treatments of the prostate. Initially both 3D-CRT and IMRT were planned for 2 Gy/fraction to a total dose of 60 Gy to the prostate. The sensitivity of the TCP and the NTCP to both conventional dose escalation and hypo-fractionation was investigated. The biological responses were calculated using the Källman S-model. The complication free tumour control probability (P+) is generated from the combined NTCP and TCP response values. It has been suggested that the alpha/beta ratio for prostate carcinoma cells may be lower than for most other tumour cell types. The effect of this on the modelled biological response for the different fractionation schedules was also investigated.
Deb
P
P
Department of Medical Radiations, RMIT University, Bundoora, Australia. pradip.deb@rmit.edu.au
Fielding
A
A
D019583:Dose Fractionation, Radiation; D006801:Humans; D008297:Male; D008954:Models, Biological; D009929:Organ Size; D009928:Organ Specificity; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011836:Radiation Tolerance; D050397:Radiotherapy, Intensity-Modulated